Jove
Visualize
Contact Us

Related Experiment Videos

Antony Lurie, Corby Fink, Geneviève Gosselin

    Virologie (Montrouge, France)
    |June 29, 2022
    PubMed
    Summary

    New research explores targeting the HIV-1 Nef protein to develop a cure for HIV. Inhibiting Nef may reverse infection-related defects, offering a promising therapeutic strategy for HIV treatment.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Linking tumor viability and immune infiltration with dual-nucleus MRI in preclinical models.

    Npj imaging·2026
    Same author

    MERTK coordinates efferocytosis by regulating integrin localization and activation.

    Journal of cell science·2026
    Same author

    Assembly and lipid-gating of LRRC8A:D volume-regulated anion channels.

    Nature communications·2025
    Same author

    Ancestral reconstruction supports that loss of Nef-mediated T cell modulation coincided with the emergence of pathogenic lentiviruses.

    Journal of virology·2025
    Same author

    The role of Nef in the long-term persistence of the replication-competent HIV reservoir in South African women.

    Journal of virology·2025
    Same author

    Association between HIV-1 Nef-mediated MHC-I downregulation and the maintenance of the replication-competent latent viral reservoir in individuals with virally suppressed HIV-1 in Uganda: an exploratory cohort study.

    The Lancet. Microbe·2025
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies

    Area of Science:

    • Virology
    • Immunology
    • Drug Discovery

    Background:

    • Antiretroviral therapy controls HIV-1 replication but does not provide a cure.
    • HIV-1 develops in vivo barriers that hinder curative approaches.
    • The accessory protein Nef is implicated in HIV-1 pathogenesis.

    Purpose of the Study:

    • To review the rationale for targeting HIV-1 Nef as a therapeutic strategy.
    • To highlight progress in identifying and developing Nef inhibitors for HIV-1 cure.

    Main Methods:

    • Review of existing literature on HIV-1 Nef function and inhibition.
    • Analysis of small molecules targeting Nef and their effects.

    Main Results:

    • Pharmacological inhibition of Nef can reverse HIV-1-induced defects.
    • Nef inhibition impacts T-cell receptor signaling, kinases, apoptosis, autophagy, and antigen presentation.
    • Small molecule Nef inhibitors show potential as therapeutic agents.

    Conclusions:

    • Nef is a promising therapeutic target for developing an HIV-1 cure.
    • Nef inhibitors demonstrate significant potential for HIV-1 treatment strategies.
    • Further development of Nef inhibitors is crucial for advancing HIV-1 cure research.

    Related Experiment Videos